Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
40.18Price to Sales
VS
Market
Sector
Industry
History
$ 5.51Close
$ 3.04 - $ 25.83 52-Week Range
Ticker Information
Ticker
BIOACompany Name
BIOAGE LABS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQBIOAGE LABS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BIOA - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 155.23M | 40.18 | $ 3.86M |
| 3/31/2025 | $ 141.61M | 0 | $ 0 |
| 12/31/2024 | $ 157.02M | 0 | $ 0 |
| 9/30/2024 | $ 739.2M | 0 | $ 0 |
| 12/31/2023 | $ 0 | 0 | $ 0 |
Key Performance Insights, Last 5 Years
- BIOAGE LABS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, BIOAGE LABS INC's average P/S has been 40.18.
- The median P/S for BIOAGE LABS INC during this period was 40.18
- BIOAGE LABS INC reached its highest P/S over the past 5 years at 40.18.
- The lowest P/S recorded by BIOAGE LABS INC in the same timeframe 40.18
BIOAGE LABS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for BIOAGE LABS INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] BIOA - Price to Sales, Last 5 years
40.18
Minimum
Jun 30, 2025
40.18
Maximum
Jun 30, 2025
40.18
Average
40.18
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |